EyePoint Pharmaceuticals, Inc. (EYPT)

NASDAQ: EYPT · Real-Time Price · USD

13.35

+0.02 (0.15%)

At close: Sep 12, 2025, 4:00 PM EDT

13.20

-0.15 (-1.12%)

After-hours: Sep 12, 2025, 6:24 PM EDT

EyePoint Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	920	523	1,088	119	415	100	Upgrade
Market Cap Growth	42.90%	-51.95%	811.96%	-71.25%	316.71%	-40.59%	Upgrade
Enterprise Value	688	292	958	8	334	125	Upgrade
Last Close Price	13.35	7.45	23.11	3.50	12.24	6.58	Upgrade
PS Ratio	16.64	12.08	23.64	2.88	11.23	2.89	Upgrade
PB Ratio	3.74	1.55	4.09	1.24	2.25	5.37	Upgrade
P/TBV Ratio	3.74	1.55	4.09	1.24	2.57	-	Upgrade
P/OCF Ratio	-	-	580.20	-	-	-	Upgrade
EV/Sales Ratio	13.26	6.75	20.82	0.21	9.05	3.62	Upgrade
Debt / Equity Ratio	0.10	0.07	0.02	0.48	0.21	2.22	Upgrade
Asset Turnover	0.17	0.11	0.17	0.19	0.21	0.42	Upgrade
Inventory Turnover	58.46	43.12	20.06	17.83	8.06	6.22	Upgrade
Quick Ratio	7.73	7.58	5.25	4.64	9.72	3.65	Upgrade
Current Ratio	8.00	7.82	5.45	5.00	10.05	4.24	Upgrade
Return on Equity (ROE)	-73.95%	-43.42%	-39.04%	-72.84%	-57.58%	-337.87%	Upgrade
Return on Assets (ROA)	-37.79%	-23.57%	-17.52%	-22.24%	-19.46%	-28.30%	Upgrade
Return on Capital (ROIC)	-45.33%	-28.88%	-22.64%	-26.94%	-24.40%	-39.32%	Upgrade
Earnings Yield	-19.06%	-25.04%	-6.51%	-85.72%	-14.08%	-45.60%	Upgrade
FCF Yield	-21.09%	-24.92%	-0.15%	-56.29%	-12.11%	-14.86%	Upgrade
Buyback Yield / Dilution	-38.62%	-44.71%	-4.25%	-29.76%	-124.04%	-23.06%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q